Cambridge Investment Research Advisors’s BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF XTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$788K Sell
17,296
-3,539
-17% -$161K ﹤0.01% 2528
2026
Q1
$956K Buy
20,835
+5,422
+35% +$251K ﹤0.01% 2209
2025
Q4
$712K Buy
15,413
+6,058
+65% +$283K ﹤0.01% 2402
2025
Q3
$436K Buy
9,355
+2,917
+45% +$134K ﹤0.01% 2800
2025
Q2
$297K Buy
+6,438
New +$293K ﹤0.01% 2986

Other funds holding XTEN

Cambridge Investment Research Advisors's XTEN Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF (XTEN) stake by 17% in Q2 2026, selling an estimated $161K and leaving 17,296 shares worth $788K. The position accounts for ﹤0.01% of the portfolio, ranked #2528.

Cambridge Investment Research Advisors first reported a position in XTEN in Q2 2025 and has held it in 5 quarters since. The position peaked at $956K in Q1 2026. 178 funds tracked by Wall St. Rank hold XTEN as of Q2 2026.

  • Cambridge Investment Research Advisors held 17,296 shares of BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF worth $788K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 3,539 BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF shares in Q2 2026, an estimated $161K.
  • BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2528 holding.
  • Cambridge Investment Research Advisors first reported a position in BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF in Q2 2025 and has held it in 5 quarters since.
  • Cambridge Investment Research Advisors's BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF position peaked at $956K in Q1 2026.
  • 178 funds tracked by Wall St. Rank held BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.